Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
C3.ai | AI | 4. nov 2024 | 24.84 | -0.76 |
C3is | CISS | 4. nov 2024 | 1.17 | -2.10 |
C4 Therapeutics | CCCC | 4. nov 2024 | 6.45 | +14.97 |
Cabaletta Bio | CABA | 4. nov 2024 | 4.00 | +7.82 |
Cabana Target Drawdown 10 ETF | TDSC | 4. nov 2024 | 24.97 | +0.05 |
Cabana Target Drawdown 7 ETF | TDSB | 4. nov 2024 | 22.28 | +0.59 |
Cable One | CABO | 4. nov 2024 | 364.04 | +1.13 |
Cabot | CBT | 4. nov 2024 | 110.09 | +0.98 |
CACI International A | CACI | 4. nov 2024 | 553.27 | 0.00 |
Cactus A | WHD | 4. nov 2024 | 61.36 | +1.29 |
Cactus Acquisition 1 A | CCTS | 4. nov 2024 | 11.65 | 0.00 |
Cadeler ADR | CDLR | 4. nov 2024 | 26.74 | +0.41 |
Cadence Bank | CADE | 4. nov 2024 | 33.02 | -0.12 |
Cadence Bank A | CADE-A | 4. nov 2024 | 21.87 | +0.46 |
Cadence Design Systems | CDNS | 4. nov 2024 | 289.34 | +2.57 |
Cadiz | CDZI | 4. nov 2024 | 3.46 | -1.14 |
Cadiz Pref ADR | CDZIP | 4. nov 2024 | 16.18 | +4.37 |
Cadre | CDRE | 4. nov 2024 | 34.88 | -0.91 |
Cadrenal Therapeutics | CVKD | 4. nov 2024 | 14.28 | -18.86 |
Cae | CAE | 4. nov 2024 | 18.05 | +0.56 |
Caesars Entertainment | CZR | 4. nov 2024 | 39.65 | +1.10 |
Caesarstone | CSTE | 4. nov 2024 | 4.15 | +2.47 |
Cal-Maine Foods | CALM | 4. nov 2024 | 87.31 | +0.23 |
Calamos Convertible High Fund | CHY | 4. nov 2024 | 11.84 | -0.25 |
Calamos Convertible Opportunities And Income Fund | CHI | 4. nov 2024 | 11.34 | 0.00 |
Calamos Dynamic Convertible & Income Fund | CCD | 4. nov 2024 | 23.91 | -0.38 |
Calamos Global Dynamic Fund | CHW | 4. nov 2024 | 6.88 | -0.36 |
Calamos Global Total Return Fund | CGO | 4. nov 2024 | 11.52 | -1.37 |
Calamos Longshort Equity & Dynamic Income Trust | CPZ | 4. nov 2024 | 15.59 | +0.19 |
Calamos Strategic Total Return Fund - Closed End Fund | CSQ | 4. nov 2024 | 17.26 | -0.06 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.